1. Retroperitoneal exploration with Vicryl mesh and fibrin tissue sealant for refractory chylous ascites
- Author
-
Christa Grant, Samir K. Gadepalli, Richard E. Overman, James D. Geiger, and Benjamin D. Carr
- Subjects
Adult ,medicine.medical_specialty ,Chyle ,Vicryl mesh ,Fibrin Tissue Adhesive ,Lesser sac ,Fibrin ,03 medical and health sciences ,0302 clinical medicine ,Refractory ,030225 pediatrics ,Chylous ascites ,medicine ,Humans ,Retroperitoneal Space ,Fibrin glue ,Chylous Ascites ,Polyglactin 910 ,Lymphatic Vessels ,Laparotomy ,Lymphatic Abnormalities ,biology ,business.industry ,Infant, Newborn ,Infant ,General Medicine ,Length of Stay ,Surgical Mesh ,Tissue sealant ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,biology.protein ,business - Abstract
Background Congenital chylous ascites poses a significant challenge in neonatal care, and often results in prolonged, complex hospital stays and increased mortality. Few effective options exist in refractory cases. Methods Patients aged 0 to 12 months with refractory chylous ascites underwent retroperitoneal exploration after medical treatment and minimally invasive therapies were unsuccessful. The retroperitoneum was completely exposed via left and right medial visceral rotation and opening the lesser sac. Visible leaks were ligated, and alternating layers of fibrin glue and Vicryl mesh were used to cover the entire retroperitoneum. Results All 4 patients had resolution of their chylous ascites. None required reoperation or reintervention for chyle leaks. All achieved goal enteral feeds at a median of 29 days postoperatively and were discharged from hospital at a median of 42 days postoperatively. Conclusions Management of chylous ascites is extremely challenging in refractory cases. Complete retroperitoneal exposure with fibrin glue and Vicryl mesh application offers a definitive, reliable therapy for achieving cessation of lymphatic leakage and ultimate recovery for patients who fail all nonoperative approaches. Study type Therapeutic. Level of evidence IV
- Published
- 2019